---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-017489"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:19:12.919601+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ChromaDex holds 2022 annual meeting; re-elects seven directors, appoints Steven Rubin as Lead Independent Director

## Summary
- All seven director nominees elected at June 16 annual meeting; votes ranged from ~28.3M to ~37.3M for.
- Shareholders ratified Marcum LLP as auditor for FY2022 with 47.7M for, 1.8M against.
- Advisory say-on-pay proposal passed with 36.0M for, 1.1M against.
- Board appointed Steven Rubin as Lead Independent Director following Kurt Gustafson's departure.
- Board committee assignments reconstituted; Rubin chairs Audit, Patrick chairs Compensation, Cohen chairs Nominating.

## SEC filing metadata
- accession: 0001628280-22-017489
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828022017489/0001628280-22-017489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828022017489/cdxc-20220616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-017489
- JSON: https://secwatch.observer/filing/0001628280-22-017489.json
- Plain text: https://secwatch.observer/filing/0001628280-22-017489.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.